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ABSTRACT
Current research points to race and
ethnicity as predictive of disparities in
access and quality of health care. A
2002 Institute of Medicine Study found
that African-American patients tend
not to receive the same type of care as
White patients, even when controlling
for socioeconomic status. Self-reported
perceptions of racial bias within the patient
provider relationship, from the patient’s
perspective, are analyzed to uncover the
subtle ways perceptions of differential
treatment based on racial bias work to
create barriers or perpetuate disparities
in health outcomes for African-American
breast cancer survivors in Michigan.
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Introduction
Breast cancer, like other forms of cancer,
is an equal opportunity killer. Cancer
cells pay no attention to the race or
ethnicity of the body in which they
reside. Cancer cells do not care about
the biology or genetics of the body they
inhabit. They go about their divisions,
invisible to detection, until they have
created a critical mass identifiable
with current diagnostic tools. When it
comes to mortality from breast cancer,
despite 40 years of civil rights struggles
in America, this equal opportunity
killer may take an unwittingly given
advantage, cloaked in the guise of
racial bias, and thereby ravage AfricanAmerican women’s lives unequally.
This study seeks to discover if
perceptions of racial bias directed
towards African-American breast cancer
survivors by health care providers is
contributing to the measured disparities
in health outcomes. While it is likely
that racial bias is not the only factor
contributing to higher mortality rates
for African-American women diagnosed
with breast cancer as compared to
White women, current evidence points
to race and ethnicity as predicative
of disparities in access and quality of
health care despite socioeconomic status
(Smedley, Stith, & Nelson, 2003). A
2002 Institute of Medicine Study found
that African-American patients of similar
socioeconomic status tend to receive
lower quality treatments than White
patients (Dept. of Health and Human
Services, 2003, p.4). The American
Cancer Society states, “additional
factors that contribute to the survival
differential include unequal access to
medical care and a higher prevalence
of coexisting medical conditions”
(American Cancer Society, 2004, p. 20).
Other studies, however, point to
additional persistent barriers even in
the absence of financial constraints
(Arbelaez, Cooper, & Saha, 2003,
p. 1713). According to National Cancer
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Institute data, death rates for AfricanAmerican women are higher than for
White women at all age ranges (National
Cancer Institute, 2000). Disparities in
outcomes, with deadly consequences
for African-American women, can be
seen in the five-year survival rates of
the disease. Data from the Surveillance,
Epidemiological, and End Results
(SEER) cancer registries, between the
years 1992-1998, document five-year
survival rates for White women at 87.6
per 100,000 and African-American
women’s five-year survival rate at 72.5
per 100,000 for the same span of time.
During the years 1979 to 1996, the rates
of breast cancer actually declined for
White women, but African-American
women and other women of color did
not experience any decline in the rate
of the disease during the same period of
time (Layde & Marabella, 2001, p. 120).
Despite these significant disparities
in health outcomes for AfricanAmerican breast cancer survivors, many
White Americans are unaware of the
inequalities in access to health care.
Researchers conducting a recent poll
commissioned by Harvard Forums on
Health found that African Americans
and Hispanics living in the United
States are much more likely to recognize
that minorities do not always have an
equal level of health care (Late, 2003,
p. 1). The same poll found that many
White Americans are unaware that such
disparities exist. In fact, the researchers
found that 57 percent of African
Americans and 49 percent of Hispanics
felt health care providers treated
minorities differently (Late, p.1)
Context for Proposed Study
This study hopes to contribute to the
ongoing dialogue between researchers
looking at ameliorating disparate health
outcomes for African-American breast
cancer survivors. Allowing women
to speak in their own words of their
experiences during treatment may
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elucidate patterns in healthcare delivery
that may be negatively influencing
outcomes. Perceptions matter.
Perceptions of bias, aside from adding
to the cognitive load women need to
manage, may compound the unequal
brunt of disease borne by women who
are already fighting for their lives.
This study addressed issues that
are difficult for some to talk about:
breast cancer and racial bias. Breast
cancer was not mentioned publicly
until the 1980s, and racism is a topic
that is often unaddressed, despite
its harmful mental and physical
consequences. Racism is not a subject
that is discussed dispassionately, nor
should it be. This study hopes to help
break the silence and push for an
ongoing, thoughtful dialogue about
how intentional or unintentional racism
may be contributing to the disparities in
outcomes for African-American breast
cancer survivors. Perhaps, because there
is no intent, White providers may be
unable to “see” racism and the biased
assumptions and actions that may flow
from this mindset. People of color,
however, are aware of the bias because
they experience its effects. This racism
invisible–intentional or not–may have
deadly implications for delivery of
quality care. This study does not seek to
castigate healthcare providers; this study
asks these questions to raise awareness
and start a dialogue about how this
racism may be telegraphed, intended or
not, to African-American women who
are being treated for breast cancer.
According to Dr. Lisa Ikemoto (2003),
“provider bias can directly translate into
less effective health care for patients of
color” (p. 96). A study conducted by
Kevin Schulman in 1999 (Schulman
as cited in Ikemoto, p. 96) surveyed
seven hundred and twenty primary
care physicians who took part in video
interviews with actors portraying male
and female, black and white patients.
Physicians referred African-American

women at the lowest overall rates. The
critical race theorist Paul Kivel argues
that we should assume that racism is
at least a part of the picture in selfreports of racial bias, and “in light of
this assumption, we should look for the
patterns involved rather than treating
most events as isolated occurrences”
(Kivel as cited in Rothenberg, 2002,
p.128). Ikemoto maintains that health
care providers trumpeting of the values
of “objectivity and universalism do not
shield them from the racism, nativism,
and ethnocentrism inherent in dominate
culture” (Ikemoto, p. 97).
Scope
The lifetime, national risk for breast
cancer in women is one in seven
(American Cancer Society, 2004, p.19).
The lifetime risk of breast cancer in
Michigan is similar to national rates.
Each year over 7,000 women are
diagnosed with breast cancer and 1,400
women die of the disease (Olszewski &
Wisdom, 2004, p. 20). Breast cancer is
second to heart disease as the leading
causes of death and, on average,
results in a loss of 18.4 years of life to
women (Olszewski & Wisdom, p. 20).
African-American women have a lower
incident rate of breast cancer compared
to White women; however, AfricanAmerican women have a significantly
higher mortality rate from the disease
(Olszewski & Wisdom, p. 20). AfricanAmerican women have a 36.9 per
100,000 rate of mortality nationally and
35.9 per 100,000 rate of mortality in
Michigan, as compared to White women
who have a 27.2 per 100,000 national
death rate and a 27.3 per 100,000 death
rate in Michigan (CDC, 2003, p. 2).
Breast cancer is not preventable;
but, if it is detected and treated early,
outcomes improve significantly, which
leads to reduced mortality and increased
survival time (Olszewski & Wisdom,
2004, p. 20). One of the most deadly
outcomes for African-American women
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with breast cancer is the fact that
African-American women are diagnosed
at distant or later stages of the disease
42.3 percent of the time, compared to
White women at 29 percent (Olszewski
& Wisdom p. 20). A late diagnosis of
breast cancer not only subjects women
to longer and more toxic treatment
regimens, late diagnoses rob women
of years of life. The overall survival
rate for African-American women is
73.5 percent compared to 88 percent
for Whites (Olszewski & Wisdom,
p. 21). Another disparity in health
care, which may contribute to poorer
outcomes for African-American breast
cancer survivors, is the fact that AfricanAmerican women are under-represented
in clinical trials of cancer drugs and
treatment regimens. Another alarming
trend, according to a recent study, found
that “the proportion of trial participants
who are black has declined in recent
years” (Murthy, Krumholz, Cary, &
Gross, 2004, p. 2726).
Other than age, more than 80 percent
of breast cancers have no known
risk factors (Olszewski & Wisdom,
2004, p. 20). Less than 10 percent of
breast cancer is due to inherited genes
(Burstein, Miller, & Mocharnuk, 2002,
p. 3). The remaining 90 to 95 percent
of breast cancers happen randomly
(Burstein, Miller, & Mocharnuk, p. 3).
Hypotheses
While the factors contributing to
disparities for African-American women’s
experiences with this disease are likely
to be multifaceted, this study seeks
to examine only a small piece of the
puzzle. This study seeks to uncover how
perceptions of bias operating within the
patient provider relationship may be
contributing to the late diagnosis and
poor prognosis for African-American
women with breast cancer. While most
healthcare providers believe prejudice
and discrimination to be “morally
abhorrent and at odds with their
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professional values, healthcare providers,
like other members of society, may not
recognize manifestations of prejudice in
their own behavior” (Smedley, Stith &
Nelson, 2002, p. 162). Therefore, with
the idea that subtle perceptions of bias
could be contributing to poor health
outcomes for African-American women
with breast cancer, this proposed study
seeks to ask the following:
• Does the perception of provider
bias change the care seeking
behavior of African-American
women or influence the
importance the women place
on preventative mammogram
screening in the first place?
• Does racial bias work to limit
physician recommendations for
follow-up screening or further
investigation such as biopsy of
African-American women?
• Do perceptions of bias create
barriers for African-American
women in access or compliance
with appropriate adjuvant
therapy?
Methods
My research project began by
identifying African-American breast
cancer survivors who were diagnosed
and treated for cancer while living in
Michigan. Several phone calls were
made to network with women to
identify survivors willing to either take
part in an interview or complete a
questionnaire for this study. Two breast
cancer survivor support groups were
contacted to solicit volunteers.
Seventy questionnaires were mailed
or emailed to breast cancer survivors,
and four completed questionnaires
were returned to me. Four women
took part in face-to-face interviews.
The same questionnaire was used for
both the survey and the interviews.

The questionnaire included a series of
open and closed questions to explore
the women’s perceptions of bias while
undergoing care. Questions were asked
to determine if perceptions of bias
limited care seeking, compliance, or
other health-related behaviors. To control
for lack of insurance coverage, only
women with some insurance coverage
were included in the sample. The age
ranges were confined to women who
are between 35 to 65 years old, and
socioeconomic status information was
gathered using questions addressing
yearly income, occupation, and number
of years of educational attainment. The
women must have received medical
treatment for breast cancer in Michigan
within the last ten years. Confidentiality
was assured to each woman through a
randomly assigned number. Questions
were asked to identify and control for
racial concordance between patients
and providers. The sample was gathered
using a snowball method, which is a
way of gathering names of potential
interviewees from the women who have
already been contacted. Initially, the
women will likely have been treated
while living in similar geographical
regions, but as the snowball expands, it
will lead to women from various locales,
which will control for regional differences
in health care service providers.
While this is a qualitative study,
insightful gleanings could serve as a
guide to better conceptualized and
tightly measured future studies. The
purpose is to probe survivors for
how perceptions of bias within the
patient provider relationship may
compound their diagnosis of cancer
in ways that White survivors do not
experience. Patterns within the reports
of the women’s experiences will be
identified to understand if subtle,
verbal and nonverbal cues, are working
to alter behavior, which may directly
or indirectly be contributing to poor
outcomes. The questionnaire probes for
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knowledge of common age appropriate
preventative screening services and
unintended barriers of access to
appropriate evidenced-based health care
for these women. Questions probe for
inappropriate comments, “gut feelings,”
and personal experiences that the
women perceive were in response to, or
resulting from, their race.
Definitions
For the purpose of this proposal,
disparities will be defined as “differences
in time spent trying to get healthcare,
information about healthcare not
being available in the same ways to
different groups, quality or availability
of insurance, transportation, and
other factors that act as deterrents”
(Casanas, Coello, Parsons, & Rocco,
2003, p. 39). Prejudice is defined in the
realm of psychology as “an unjustified
negative attitude based on a person’s
group membership” (Smedley, Stith,
& Nelson, 2002, p. 162). When
prejudice is reasoned to be a valid
individual worldview it is likely to
become normative for that individual
(Smedley, Stith, & Nelson, p. 162). For
the purposes of this study, healthcare
providers could be physicians, physician
assistants, nurses, or other allied
healthcare workers.
History of Health Care Inequality
Dr. Martin Luther King Jr. once said, “of
all the forms of inequalities, injustice
in health is the most shocking and the
most inhumane” (cited in Farmer, 2003,
p. 173). Despite the gains made for
people of color since the start of the civil
rights movement, disparities in health
outcomes continue to this day. This
issue is important from moral, personal,
and economic perspectives. Disparities
in health outcomes exact costs in dollars
for all of us; however, people of color
disproportionately pay with their lives.
Disparities cause avoidable disabilities
and escalations of poorly managed
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chronic conditions result in expensive,
avoidable complications, and may
lead to increases in hospitalizations.
This downward loop of worsening
health leads to increased costs for the
individual and for the public health
programs many people depend on for
health care (National Health Disparities
Report, 2003. p. 6).
The idea of overt discrimination may
seem alien to most people born after the
civil rights struggles of the 1960s in the
United States. Books and films shape
knowledge of life in pre-civil rights
America for many citizens. For others
who lived it, the first-hand accounts
are woven into familial history, shaped
with each retelling of the day-to-day
struggles for the basic human rights
each American holds dear. Feagin and
Sikes (1994, p. 204) report that one
historic study of overt discrimination
is the Tuskegee Study, which began in
1932. According to Fegin and Sikes, the
American government promised 400
African-American men free treatment for
“Bad Blood” a euphemism for syphilis.
However, they report that medical
treatment was withheld, and the study
allowed the men to go untreated for
syphilis four decades. No new drugs
were tested and no effort was made to
establish the benefits of any of the older
forms of treatment.
A more recent study, conducted
in 2000, found that doctors rated
African-American patients as less
intelligent, less educated, and less likely
to comply with medical advice than
White patients, even after income and
education levels were controlled for
(Smedley, Stith, & Nelson, 2002,
p. 11). Another study found that
African-American respondents were less
likely to trust their doctors and more
likely to trust their insurance plans
(Boulware, Cooper, LaViest, & Ratner,
2003, p. 1). Additionally, studies show
that African-American patients rank
their doctor visits less participatory

when there is lack of racial concordance
between patients and providers despite
provider gender (Cooper-Patrick, et al.
1999, p. 588). Research does suggest,
“provider’s diagnostic and treatment
decisions, as well as feelings about
patients, are influenced by patients’
race and ethnicity” (Smedley, Stith, &
Nelson p. 11).
Support for the hypotheses of this
proposal can be found in a study
done in 2002, which suggests three
possible mechanisms working to create
disparate health outcomes as measured
in minority patients. These mechanisms
are located within the provider side of
the exchange and include: “bias against
minorities, greater clinical uncertainty
when working with minority patients,
and beliefs or stereotypes held by the
provider about the behavior or health of
minorities” (Smedley, Stith, & Nelson,
2002, p. 9). Studies show that minority
patients are aware of the bias held by
providers towards them, and recent
studies report that minority patients
feel they have lower quality interactions
with their doctors (Arbelaez, Cooper, &
Saha, 2003, p. 1713). The hypotheses of
this proposal ask if patients’ awareness
of provider bias holds implications for
their health outcomes. A study that
lends credence to the hypotheses of this
proposal presents evidence that even
“small numeric differences on perceptual
measures can have important effects
on health and health care” (Doescher,
Fiscella, Franks, & Saver, 2000,
p. 1161). This study found that a
“1-point change in the medical
skepticism score (range 1-5) was
associated with an 11 percent increase
in total mortality” (Doescher, Fiscella,
Franks, & Saver, p. 1161).
Bias may be communicated in ways
from providers to patients without
the providers’ awareness that such
attitudes are being projected. Bias may
be overt and conscious, or may be
unconscious, and due to origins which
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“arise from virtually universal social
categorization processes, bias may exist,
often unconsciously, among people who
strongly endorse egalitarian principles”
(Smedley, Stith, & Nelson, 2002, p. 10).
These same researchers have found that
“socially conditioned implicit prejudice
may be manifested in healthcare
providers’ nonverbal behaviors reflecting
anxiety (e.g., increased rate of blinking),
aversion (e.g., reduced eye contact) or
avoidance (e.g., more closed postures)
when interacting with minority rather
than white patients” (Smedley, Stith
& Nelson, p. 162). This awareness of
provider bias may perpetuate disparate
health outcomes by working to alienate
patients from the treatment decisionmaking process.
Racism is present in every day life
and is obvious in popular culture
(Hall, Harrell, & Taliaferro, 2003,
p. 243). Racism is not only present in
individual acts of bias and interpersonal
discrimination, it is also present in the
relationship between health and health
outcomes (Hall, Harrell, & Taliaferro,
p. 243). These acts of discrimination
and interpersonal bias act as “salt in the
wounds previously inflicted by a host of
negative life events whose relationship to
racism in often cloaked” (Hall, Harrell,
& Taliaferro, p. 243).
Social cognition theorists study how
people make sense of other people
and the “processes that underlie social
perception, social interaction, and
social influence” (Fu & van Ryn, 2003,
p. 248). Psychologists have focused on
social cognition for several decades,
which has resulted in a “massive body
of evidence with significant implications
for understanding how race/ethnicity
influences provider behavior” (Fu &
van Ryn, p. 248). Studies show that
patient perceptions are important and
do recognize that communication, both
verbal and nonverbal, influence
patient’s behavior (Cooper-Patrick, et al.,
1999, p. 588).
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With the knowledge of race and
ethnicity as an influence of provider
behavior, this study suggests that further
investigation of how intentional or
unintentional bias of providers works
to create poorer health outcomes for
African-American women. Studies
show that African-American women are
less likely to receive recommendations
for mammography at age appropriate
intervals (Fu & van Ryn, 2003, p. 252).
Women who are less likely to receive
recommendations for mammograms are
more likely to be diagnosed at a later,
less treatable stage of disease. Literature
shows “that to a large extent, racial/
ethnic bias differentials seen in staging
are the result of lower screening rates”
(Cutter & Jacobellis, 2002, p. 1148).
According to the Physicians Insurers
Association of America (as cited
in Steyksal, 1996, p. 1), “the most
expensive and common medico legal
claim against physicians is delay in the
diagnosis of breast cancer.”
There are many confounding
factors within the study of disparities,
including racial and gender patient/
provider concordance, type of hospital
or clinic or geographic variations,
co-morbidities, and compliance with
medical recommendations (Smedley,
Stith, & Nelson, 2002, p. 42). Yet
studies show that despite adjusting
for all of these confounding factors,
disparities in outcomes for AfricanAmericans continue to predominate
in cardiovascular care (Smedley, Stith,
& Nelson, p. 42). Though most
studies have examined racism and its
contributions to disparities in cardiac
care, fewer studies have examined the
role of bias in relation to breast cancer.
It is a logical question to ask if the
same sort of mechanisms documented
in disparate outcomes in heart disease
could be contributing to disparate breast
cancer outcomes.

Critical Race Theory, Social
Constructs and Access to Quality
Health Care
The impetus for this study is grounded
in critical race theory. The disparities
minorities face in access to quality
health care, as compared to people in
the majority population, grow out of
historic and contemporary inequities
(Smedley, Stith, & Nelson, 2004, p. 1).
The complex tangle of health systems,
administrative and bureaucratic
processes and policies, as well as
individual healthcare providers and
patients they treat, coupled with the
patient provider interactions, weave
together to create a complex matrix that
contribute to inequalities in treatment for
minorities in the United States (Smedley,
Stith, & Nelson, p. 1). This complex
matrix also includes racial and ethnic
stereotyping, bias, socioeconomic status,
language, and cultural barriers, which
work to limit access and quality of health
care (Smedley, Stith, & Nelson, p. 1)
Critical race theory has grown out
of examinations of the legal system of
the 1970s in America. Legal scholars
Derrick Bell and Richard Delgado began
to challenge the slow pace of racial
reform since the Civil Rights Movement
of the 1960s (Jeris & McDowell, 2004,
p. 82). The advances of the Civil Rights
Movement have been legally challenged
to this day in an attempt to disregard
race for a “color-blind meritocracy”
(Jeris & McDowell, p. 82). Critical race
theory offers a broad social perspective
for assessing the speed and direction of
this country’s polices in relationship to
race and has been used in education,
law, and the social sciences as a lens
with which to analyze historical power
relationships between groups of people
in this country (Jeris & McDowell, p. 82).
Critical race theory recognizes the
ongoing implications for people that
have grown out of the legal history of
this country’s racist past.
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Dr. Harold Freeman, 1997 Chair of
the President’s Cancer Panel, quoting
Albert Einstein, said, “What you see
depends on where you stand” (Einstein
as cited in Freeman, 1997, p. 2).
Einstein made his remarks to describe
the point of view from which scientists
approach scientific investigation of race,
which he knew all too well, are often
shaped by social and political thought.
Because there is no language to
describe the experience of racism or
of growing up a minority in America,
critical race theorists “attempt to inject
the cultural viewpoints of people of
color, derived from a common history of
oppression” (Casanas, Coello, Parsons,
& Rocco, 2003, p. 39).
The assumption that underlies
critical race theory is the idea that
many interactions of privilege that
Whites take for granted happen without
any conscious thought. In everyday
interactions, the privileges and power of
invisibility happen with no awareness
of how these interactions might be
different for those who do not share the
same physical features. These privileges,
apart from their intentions or conscious
choices, influence lives in large and small
ways. Whites do not often face racial
profiling which affects, for example, the
ability to move freely through a store
without security people following, or
driving a car without worrying if skin
color will single the driver out for undue
harassment by law enforcement.

more likely to talk about their health
issues with a provider of the same race;
this was true both in the questionnaire
and within the interviews. The women
all responded that they did not know
how their care might improve if their
healthcare providers were of the same
race. The questionnaire respondents
(QR) and the interviewees reported
that the healthcare personnel they
encountered always treated them with
dignity and respect. They all responded
that racism has not influenced the care
they received.
All of the women reported that they
were able to take all of the medications
and follow all of the guidelines and
recommendations for their illness. They
all reported they were given ample time
for questions, and they all felt they
were well informed by their healthcare
providers. Every woman reported having
a primary caregiver and reported having
trust in this person. The follow-up
cycles varied for each woman, and they
reported being seen by surgeons and
oncologists. The QRs and interviewees
were all in their early fifties when
diagnosed, and none of the women
reported any recurrences of disease.
It is interesting to note that the
women who took part were at Stage I
when diagnosed with cancer. The
women were of similar socioeconomic
backgrounds, worked in white-collar
occupations, and all reported having
some college education.

Discussion
The women who took part in
interviews (n=4) and responded to
the questionnaire (n=4) reported
experiencing no perceptions of racial
bias during their treatment for cancer.
Every woman reported being treated by
healthcare providers of a race different
from her own, and each woman
responded that her relationships with
healthcare providers were excellent.
None of the women said they would be

Limitations
The study design may have contributed
to the non-findings. Perhaps women
who have had negative experiences with
healthcare providers are less likely to
take part in the first place. Perhaps it is
too frightening for women to consider
perceptions of bias while being treated
for a potentially life threatening disease.
The questionnaire and interview
question design was not pre-tested,
and the questions chosen could be
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altered to probe more deeply into the
subtle interactions between patients and
providers. Gender bias is likely to be a
confounding issue and difficult to tease
out within this study of perceptions
of bias and health outcomes. All of
the women who took part in this
study were from similar education and
socioeconomic backgrounds. Each
woman was Stage I at diagnosis. It is
important to note there is little regional
variability among the women in the
current sample. The small sample size
offers a narrow snapshot of the range of
interactions expected to be analyzed for
this study.
In response to concerns about the
bias that can occur when measures of
health status are based on self-reports,
Williams, Neighbors, and Jackson
(2003) conducted a longitudinal study
of African Americans which revealed
that “no association between baseline
measures of major depression or
psychological distress and subsequent
reports of racial discrimination” (p. 204).
Researcher bias is another limitation,
especially for the face-to-face interviews.
A more robust study design is planned
for winter 2005, which will include
ethnographies of African-American
and White survivor group meetings,
to better capture the essence of patient
provider relationship.
Conclusion
The data collected from the women who
took part in this study does not uncover
perceptions of bias within the patient
provider relationship. This is more likely
to be due to the study design than a
conclusive finding. Researchers who
conducted a study on discrimination
in health outcomes recently concluded
that, “one of the critically important
issues for future research is to improve
the assessment of discrimination in
health studies” (Williams, Neighbors,
& Jackson, 2003, p. 202). These
researchers also acknowledge the serious
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methodological issues and inadequate
assessment of discrimination in health
status in many studies, but states that
“nonetheless, the consistency of the
finding that discrimination is associated
with higher rates of disease is quite
robust” (Williams, Neighbors, &
Jackson, p. 202).
As Dr. Sandra Harding (cited in
National Cancer Institute, 1997, p. 14)
said, “individual scientists can best avoid
racist bias in their work by identifying
their own values and studying the
history, philosophy, and sociology of
science; and since human values change
slowly, the lessons of the past remain of
great relevance.” Future research must
strive to measure the way perceptions
of discrimination adversely effect
health behaviors and create negative
emotional states, which may contribute
to physiological responses and their
subsequent impact on health (Williams,
Neighbors, & Jackson, 2003, p. 205).
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